Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of candida-infected denture stomatitis

Journal of Contemporary Dental Practice

Volumn 11, Issue 2, 2010, Pages 17-24

  Khozeimeh, Faezeh ^a   Shahtalebi, Mohammad Ali ^a   Noori, Mojtaba ^a   Savabi, Omid ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Candida; Denture stomatitis; Ketoconazole; Orabase; Topical treatment

Indexed keywords

ANTIFUNGAL AGENT; CARBOXYMETHYLCELLULOSE; DRUG CARRIER; DRUG DERIVATIVE; KETOCONAZOLE; ORABASE;

AGED; ARTICLE; BACTERIAL COUNT; BUCCAL DRUG ADMINISTRATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTURE; FOLLOW UP; HUMAN; MICROBIOLOGY; MIDDLE AGED; MOUTH MUCOSA; OINTMENT; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; TABLET; THRUSH;

ADMINISTRATION, BUCCAL; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; CARBOXYMETHYLCELLULOSE; COLONY COUNT, MICROBIAL; DENTURE, COMPLETE; DRUG CARRIERS; FOLLOW-UP STUDIES; HUMANS; KETOCONAZOLE; MIDDLE AGED; MOUTH MUCOSA; OINTMENTS; STOMATITIS, DENTURE; TABLETS;

EID: 77954754614     PISSN: None     EISSN: 15263711     Source Type: Journal    
DOI: 10.5005/jcdp-11-2-17     Document Type: Article

References (24)

1. Greenberg M, Glick M, Ship JA. Burket's oral medicine. 11th ed. Hamilton, Ontario: BC Deeker; 2008. p. 81-4.
2. Axéll T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odontol Revy Suppl. 1976; 36:1-103.
3. Budtz-Jørgensen E. Oral mucosal lesions associated with the wearing of removable dentures. J Oral Pathol. 1981; 10(2):65-80.
4. Pindborg JJ, Sørensen NA. [Oral mucosa conditions and denture status in 127 nursing home residents]. Tandlaegebladet. 1983; 87(9):307-11.
5. Salonen L, Axéll T, Helldén L. Occurrence of oral mucosal lesions, the influence of tobacco habits and an estimate of treatment time in an adult Swedish population. J Oral Pathol Med 1990; 19(4):170-6.
6. McMullan-Vogel CG;,Jüde RD, Ollert MW, Vogel CW. Serotype distribution and secretory acid proteinase activity of Candida albicans isolated from the oral mucosa of patients with denture stomatitis. Oral Microbiol Immunol. 1999; 14(3):183-9.
7. Budtz-Jörgensen E. The significance of Candida albicans in denture stomatitis. Scand J Dent Res. 1974; 82(2):151-90.
8. Jeganathan S, Lin CC. Denture stomatitis- a review of the aetiology, diagnosis and management. Aust Dent J. 1992; 37(2):107-14.
9. Könsberg R, Axéll T. Treatment of Candidainfected denture stomatitis with a miconazole lacquer. Oral Surg Oral Med Oral Pathol. 1994; 78(3):306-11.
10. Lyon DG, Chick AO. Denture sore mouth and angular cheilitis: a preliminary investigation into their possible association with Candida infection. Dent Pract 1957; 7:212-7.
11. Budtz-Jorgensen E, Bertram U. Denture stomatitis I. The etiology in relation to trauma and infection. Acta Odontol Scand. 1970; 28(1):71-92.
12. Carter GM, Kerr MA, Shepherd MG. The rational management of oral candidosis associated with dentures. N Z Dent J. 1986; 82(369):81-4.
13. Parvinen T, Kokko J, Yli-Urpo A. Miconazole lacquer compared with gel in treatment of denture stomatitis. Scand J Dent Res. 1994; 102(6):361-6.
14. Amanlou M, Beitollahi JM, Abdollahzadeh S, Tohidast-Ekrad Z. Miconazole gel compared with Zataria multiflora Boiss. gel in the treatment of denture stomatitis. Phytother Res. 2006; 20(11):966-9.
15. Koray M, Ak G, Kurklu E, Issever H, Tanyeri H, Kulekci G, Guc U. Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis. Oral Dis. 2005; 11(5):309-13.
16. Lopez-De-Blanc SA, Salati-De-Mugnolo N, Femopase FL, Benitez MB, Morelatto RA, Astrada-De-Verde L, Masih D. Antifungal topical therapy in oral chronic candidosis. A comparative study. Med Oral. 2002; 7(4):260-70.
17. Diz Dios P, Vázquez García E. Ketoconazole resistant oral candidiasis in HIV-infected patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 84(1):3-4.
18. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE; Infectious Diseases Society of America. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004; 38(2):161-89.
19. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Drugs @ FDA. Drug detail: Nizoral [Internet]. Washington (DC): U.S. Department of Health and Human Services [cited 2007 Feb 15]. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails
20. Van Roey J, Haxaire M, Kamya M, Lwanga I, Katabira E. Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. J Acquir Immune Defic Syndr. 2004; 35(2):144-50.
21. Bensadoun RJ, Daoud J, EI Gueddari B, Bastit L, Gourmet R, Rosikon A, Allavena C, Céruse P, Calais G, Attali P. Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer. Cancer. 2008; 112(1):204-11.
22. Silverman S Jr, Gallo JW, McKnight ML, Mayer P, deSanz S, Tan MM. Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996; 82(4):402-7.
23. Graybill JR, Vazquez J, Darouiche RO, Morhart R, Greenspan D, Tuazon C, Wheat LJ, Carey J, Leviton I, Hewitt RG, MacGregor RR, Valenti W, Restrepo M, Moskovitz BL. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients. Am J Med. 1998;104(1):33-9.
24. Lyon JP, de Resende MA. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers. Oral surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102(5):632-8.